Expression of CD180, a toll-like receptor homologue, is up-regulated in children with Kawasaki disease

Journal of Molecular Medicine

Volumn 84, Issue 2, 2006, Pages 168-174

  Imayoshi, Miyoko ^a,b,c   Yamamoto, Shuichi ^a   Watanabe, Mamie ^a   Nishimura, Shinji ^a   Tashiro, Katsuya ^a   Zaitsu, Masafumi ^a   Tasaki, Hakaru ^a   Kimoto, Masao ^a   Hamasaki, Yuhei ^a   Ishii, Eiichi ^a,b  

^a SAGA UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c Takashima General Hospital   (Japan)

Author keywords

CD180; Kawasaki disease; Toll like receptor; Viral infection

Indexed keywords

CLUSTER OF DIFFERENTIATION 180 RECEPTOR; DOUBLE STRANDED RNA; MESSENGER RNA; RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CELL FUNCTION; CELL STIMULATION; CHILD; FLUORESCENCE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MUCOCUTANEOUS LYMPH NODE SYNDROME; RECEPTOR UPREGULATION; UPREGULATION; VIRUS INFECTION;

ANTIGENS, CD; B-LYMPHOCYTES; BACTERIAL INFECTIONS; CELLS, CULTURED; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA, HUMAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLY I-C; REFERENCE VALUES; TOLL-LIKE RECEPTORS; UP-REGULATION;

EID: 32044438879     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-005-0010-8     Document Type: Article

References (21)

1. Cuttica RJ (1997) Vasculitis, Kawasaki disease, and pseudovasculitis. Curr Opin Rheumatol 9:448-457
2. Kato H, Sugiyama T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379-1385
3. Suzuki A, Kamiya T, Arakaki, Kinoshita Y, Kimura K (1994) Fate of coronary arterial aneurysms in Kawasaki disease. Am J Cardiol 74:822-824
4. Akiyama T, Yashiro K (1993) Probable role of Streptococcus pyogenes in Kawasaki disease. Eur J Pediatr 152:82-92
5. Abe J, Onimaru M, Matsumoto S, Noma S, Baba K, Ito Y, Kohsaka T, Takeda T (1997) Clinical role for a superantigen in Yersinia pseudotuberculosis infection. J Clin Invest 99:1823-1830
6. Marchette NJ, Melish ME, Hicks R, Kihara S, Sam E, Ching D (1990) Epstein-Barr virus and other herpesvirus infections in Kawasaki syndrome. J Infect Dis 161:680-684
7. Yoshioka T, Matsutani T, Iwagami S, Toyosaki-Maeda T, Yutsudo T, Tsuruta Y, Suzuki H, Uemura S, Takeuchi T, Koike M, Suzuki R (1999) Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease. Immunology 96:465-472
8. Takeshita S, Nakatani K, Kawase H, Seki S, Yamamoto M, Sekine I, Yoshida S (1999) The role of bacterial lipopolysaccharide-bound neutrophils in pathogenesis of Kawasaki disease. J Infect Dis 179:508-512
9. Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH (2001) CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 184:940-943
10. Miyake K, Yamashita Y, Hitoshi Y, Takatsu K, Kimoto M (1994) Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kd molecule: unresponsiveness of X-linked immunodeficient B cells. J Exp Med 180:1217-1224
11. Miyake K, Yamashita Y, Ogata H, Sudo T, Kimoto M (1995) RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J Immunol 154:3333-3340
12. Yamashita Y, Miyake K, Miura Y, Kaneko Y, Yagita H, Suda T, Nagata S, Nomura J, Sakaguchi N, Kimoto M (1996) Activation mediated by RP105 but not CD40 makes normal B cells susceptible to anti-IgM-induced apoptosis: a role for Fc receptor colligation. J Exp Med 184:113-120
13. Miyake K, Shimazu R, Kondo J, Niki T, Akashi S, Ogata H, Yamashita Y, Miura Y, Kimoto M (1998) Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression. J Immunol 161:1348-1353
14. Ogata H, Su I, Miyake K, Nagai Y, Akashi S, Mecklenbrauker I, Rajewsky K, Kimoto M, Tarakhovsky A (2000) The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J Exp Med 192:23-29
15. Okada Y, Shinohara M, Kobayashi T, Inoue Y, Tomomasa T, Kobayashi T, Morikawa A (2003) Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 143:363-367
16. Divanovic S, Trompette A, Atabani SF, Madan R, Golenbock DT, Visintin A, Finberg RW, Tarakhovsky A, Vogel SN, Belkaid Y, Kurt-Jones EA, Karp CL (2005) Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol 6:571-578
17. Rowley AH, Baker SC, Shulman S, Garcia FL, Guzman-Cottrill JA, Chou P, Terai M, Kawasaki T, Kalelkar MB, Crawford SE (2004) Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J Infect Dis 190:856-865
18. Stunz LL, Busch LK, Munroe ME, Sigmund CD, Tygrett LT, Waldschmidt TJ, Bishop GA (2004) Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture. Immunity 21:255-266
19. Hunziker L, Recher M, Macpherson AJ, Ciurea A, Freigang S, Hengartner H, Zinkernagel RM (2003) Hypergammaglobulinemia and autoantibody induction mechanisms in viral infection. Nat Immunol 4:343-349
20. Furukawa F, Ohshio G, Hamashima Y (1986) Possible polyclonal B cell activation in mucocutaneous lymphonode syndrome. Eur J Pediatr 145:104-108
21. Koarada S, Tada Y, Ushiyama O, Morito F, Suzuki N, Ohta A, Miyake K, Kimoto M, Nagasawa K (1999) B cells lacking RP105, a novel B cell antigen, in systemic lupus erythematosus. Arthritis Rheum 42:2593-2600